液態切片市場火熱！ 多體學血檢公司Freenome剛募完D輪3 ...

2024年3月15日 — Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their ...

2024年4月2日 — In a prespecified analysis, the Freenome blood test for CRC screening demonstrated 79.2% sensitivity in detecting colorectal cancer (Stage I: ...

2023年2月22日 — Biotech firm Freenome creates diagnostic tests to detect life-threatening diseases like cancer in the earliest stages with Google Cloud.

2024年4月25日 — Freenome, a developer of blood tests for early cancer detection, said it is eliminating just over 100 jobs, or about 20% of its staff, in a ...

Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.

Freenome | 30700 位LinkedIn 關注者。Outpacing cancer starts with early detection | Freenome is a high-growth biotech company on a mission since 2014 to ...

Freenome's mission is to detect cancer in its earliest, most treatable stages and make screening easy and accessible for everyone. Foundational to Freenome's ...

2021年12月8日 — Freenome 平台使用機器學習人工智慧來分析常規抽血中的基因體、轉錄體、甲基體和蛋白質體學數據，以發現癌症的最早跡象，包括來自腫瘤和非腫瘤來源的生物 ...

2022年1月12日 — 多體學(multiomics)血液檢測開發公司Freenome， 於去年底完成D輪3億美元募資，美國時間11日，Freenome再宣布，獲得製藥、診斷巨頭羅氏(Roche)2.9億 ...